Topic: Plavix
Both of the articles I just read, are well written, as well as being right; I have lived with CAD now for about five years. I have to take heavy aspirin, and Plavix, which is a blood thinner. Avandia was the one ...
Drugmaker Bristol-Myers expected to focus on new drug approvals, more on horizon in 3Q reportBristol-Myers Squibb Co., the maker of popular blood thinners Plavix and Coumadin, is likely to spend some time trumpeting its latest acquisition, plus two recent drug approvals and ...
Bristol-Myers Squibb (BMY) Q2 2010 Earnings Call July 22, 2010 10:30 am ET. Our performance is good despite the headwind resulting from the implementation of the healthcare reform in the U.S. and from the economic crisis in Europe. Based on this data, ...
Bristol-Myers sees big jumps in 1Q sales, profit, but lowers forecast on health overhaul costsDrugmaker Bristol-Myers Squibb Co. on Thursday reported double-digit jumps in first-quarter sales and profit, beating Wall Street expectations, but it lowered its 2010 profit forecast by a nickel ...
Commenting on the Group's performance in Q1 2010, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "During this first quarter, our growth platforms delivered double-digit growth enhanced by recent targeted acquisitions and A/H1N1 vaccine sales. Solid Q1 2010 performance(2) -- Sales growth ...